Učitavanje...
Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia
Histone deacetylases (HDACs) are a key component of the epigenetic machinery regulating gene expression, and behave as oncogenes in several cancer types, spurring the development of HDAC inhibitors (HDACi) as anticancer drugs. This review discusses new results regarding the role of HDACs in cancer a...
Spremljeno u:
| Izdano u: | Br J Cancer |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4800301/ https://ncbi.nlm.nih.gov/pubmed/26908329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.36 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|